Arkolith/Insider Trading/APYX/Form 4

Waldman Lawrence

DirectorApyx Medical Corp (APYX) · full profile →Form 4 · filed Jul 19, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 12, 2023Option exercise(M)5K$2.97$16K5K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 12, 2023Option exercise(M)12K—$00

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-23-024899) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML